Invited Speakers

Professor Jason S. Lewis
Vice Chair of Research, Chief Attending
Radiochemistry & Imaging Sciences Service

Director
Radiochemistry & Molecular Imaging Probe Core at Memorial Sloan-Kettering Cancer Center.

Dr. Lewis holds a joint appointment in the Molecular Pharmacology and Chemistry Program at the Sloan-Kettering Institute. He did his postdoctoral work with Professors Carolyn J. Anderson and Michael J. Welch at the Washington University School of Medicine (WUSM).  Subsequently he joined the WUSM faculty as an Assistant Professor of Radiology (2003-2008) at which point he joined MSKCC.

Dr. Lewis’ research program is a molecular imaging-based program focused on radiopharmaceutical development as well as the study of multimodality (PET, CT & MRI) small- and biomolecule-based agents and their clinical translation. He has published more than 120 peer-reviewed articles as well as numerous book chapters and reviews. His research is supported by grants from the United States Department of Defense and the National Institutes of Health.

John Valliant, PhD
Associate Professor
McMaster University, Department of Chemistry and Chemical Biology

Chief Executive Officer
Centre for Probe Development and Commercialization

Dr. Valliant, an Associate Professor in the Department of Chemistry and Chemical Biology at McMaster University, is internationally recognized for his work in radiopharmaceutical chemistry. His current research focuses on developing new radiolabeling methods and compound discovery strategies to create clinically relevant molecular imaging probes and therapeutic radiopharmaceuticals.

John is also the CEO of the Centre for Probe Development and Commercialization (CPDC), a non-profit corporation established in 2008 through John’s leadership in envisioning and developing the concept for the Centre, bringing together the necessary high caliber partners and securing the funding for start-up. The CPDC is focused on bridging the gap between academia and industry, by enabling the development and commercialization of promising imaging probes and associated technologies. The Centre employs more than 70 research scientists, production technologists, quality assurance specialists and regulatory affairs experts focused on discovering, developing and distributing the next generation of molecular imaging probes. The CPDC also plays an important role in Ontario’s health care system, manufacturing and delivering a reliable, daily supply of imaging probes to hospitals across the province.

In 2009, John was selected as one of Canada’s Top 40 Under 40, a distinction that recognizes his work at CPDC and McMaster University to advance molecular imaging probe technologies, improve patient care and spur on economic growth through commercialization of Canadian ideas. The award also acknowledges his commitment to education and training at McMaster and within the imaging industry - a dedication to mentorship that has helped position graduates from the Valliant group to take on key leadership roles in both academic and industry settings in Canada and abroad.

John has published more than 100 papers, patents and conference proceedings.  He has been invited to speak at scientific conferences and leading research centres the world over, including a highlight of giving the plenary lecture at the 2009 Society of Nuclear Medicine meeting. John completed his PhD at McMaster University, and followed with a post-doctoral fellowship under the joint supervision of professors Alun G. Jones (Harvard) and Alan Davison (MIT). Returning to McMaster in 1999, he became an assistant professor and was promoted to associate professor in 2005.

Suzanne Lapi, PhD
Assistant Professor of Radiology, Washington University, St. Louis

Suzanne is an assistant professor in the Department of Radiology currently at Washington University in St. Louis.    She oversees production of radiometal PET radionuclides and is funded through grants supported by NIH and DOE.

Her research interest is two pronged with a focus on production of radioisotopes and applications of isotopes in medical imaging.  Her production group currently produces copper-64 and zirconium-89 for both internal and external users (over 30 academic and industry centers currently supplied).  Her research group is also focused on radiolabeled antibodies and peptides for PET imaging.

Isabel Rego Santos
Researcher at Centro Tecnológico e Nuclear (CTN) Instituto Superior Técnico, Universidade Técnica de Lisboa
Professor in the Department of Chemistry and Biochemistry, University of Lisbon
Head of the Radiopharmaceutical Sciences Group/CTN//IST

Isabel Santos has graduated in Chemical Engineering from the Instituto Superior Técnico (IST) Technical University of Lisbon, Portugal, where she has also received her PhD and Aggregation in Chemistry. She has done Post-Doctoral studies in the Professor Henri Kagan Group, Laboratoire de Catalyse Moléculaire, Université Paris-Sud, France, has been as an invited Professor at the University of Bourgogne and as invited scientist in different International Universities and Research Laboratories. Her current scientific interests are on the chemistry and radiochemistry of compounds for in vivo biological applications.

In January 2000, she was appointed as leader of the Radiopharmaceutical Sciences Group at the CTN/IST (ex-ITN). In this multidisciplinary group, Isabel Santos and co-workers are interested in making innovative tools for single photon emission (SPECT) and positron emission tomography (PET) molecular imaging and targeted radiotherapy. These tools are designed to target specifically biomarkers related with cancer and neurodegenerative diseases. She is an Invited Professor at the University of Lisbon, and has (co)authored about 180 scientific publications in International Journals with peer review, patents and book chapters. She has been invited to speak at scientific conferences and Research Centers/Universities (49), being also co-author of 86 oral presentation and 192 posters. During her research carrier she has interact with about 228 national and international scientists.

She is member of Commissions and Committees of National and International Science Foundations and IAEA, acting also as referee for several international Journals. Her R&D has been supported by Grants from Portuguese Science Foundation, European Commission and Pharmaceutical Companies.